Vaccine-Preventable Diseases

Top Story

Influenza vaccine 48% effective in US

Influenza vaccine 48% effective in US
February 24, 2017

Read the Perspective from Donald Kaye, MD, MACP

New interim estimates indicate that the influenza vaccine is 48% effective in the United States. Meanwhile, influenza activity remains elevated in many parts of the country, and the number of deaths attributed to pneumonia and influenza continue to be higher than the epidemic threshold, according to a pair of CDC reports.

“Annual influenza vaccination is the first and best defense to protect against influenza infection,” Lenee Blanton, MPH, of the CDC’s Influenza Division, National Center for Immunization and Respiratory Diseases, and colleagues wrote in a recent MMWR. “Even during seasons when [vaccine effectiveness (VE)] is reduced, vaccination can offer substantial benefit and might reduce the likelihood of severe outcomes such as hospitalization and death.”

Meeting News

ACIP recommends single-dose revaccination for infants born to HBV-infected mothers

February 22, 2017
The Advisory Committee on Immunization Practices voted today in favor of single-dose alternative to 3-dose revaccination for infants born to hepatitis B surface…
In the Journals

Smear-negative youth screened for TB reveal low risk of transmission in schools

February 21, 2017
Researchers in Italy found that the Mycoplasma tuberculosis transmission rate in school settings from smear-negative index cases were very low, particularly in those
In the Journals

Men-C-Con vaccine more economical vs. Men-4-Con vaccine in Quebec

February 20, 2017
Monovalent C meningococcal conjugate vaccine was a more economical option compared with a quadrivalent ACWY vaccine due to low epidemiologic factors for disease risk…

Prevention of Meningococcal Infections in the First 2 Years of Life

Pediatric Annals, August 2013, Volume 42 Issue 8
CME Educational Objectives 1.Review the current epidemiology of meningococcal disease in children. 2. Discuss the…
More »

Operation Immunization 2016: Enhancing HPV Immunization

This activity is supported by an educational grant from Merck & Co., Inc.

During the last decade, several new vaccines, including the meningococcal conjugate (MCV4), tetanus, diphtheria…
More »
Meeting News Coverage

VIDEO: Limited knowledge about Zika poses challenge in vaccine development

April 25, 2016
More »

ID experts anxious, uncertain about Trump presidency

December 2, 2016
Days after winning the White House, President-elect Donald J. Trump declared during a TV interview that he would try to keep in place parts of the…

Meeting News

Debating the benefits and risks of vaccination against meningococcal disease

December 1, 2016
Although many pediatricians in the U.S. recommend vaccinating against serogroup B meningococcal disease to the parents of their patients, questions…

In the Journals

Association with Tdap, meningococcal vaccine requirements could increase HPV vaccination uptake

November 29, 2016
School-entry HPV vaccination requirements had a minimal impact in HPV prevention coverage for adolescent girls, though state vaccination requirements…

Meeting News

Enhanced diagnostic methods, treatment imperative for TB elimination

November 28, 2016
The CDC reported that tuberculosis is the leading pathogen killer in the world again, with between 1.8 million to 10.4 million people infected…

Meeting News

RSV vaccine development theory includes three approaches to treatment

November 28, 2016
NEW YORK — Revolutionary developments toward respiratory syncytial virus prevention and vaccination plans, such as inhibiting RNA, targeting…

In the Journals Plus

Two-dose regimens of Gardasil 9 noninferior to three-dose regimens

November 28, 2016
Two-dose regimens of Gardasil 9 separated by 6 or 12 months in girls and boys aged 9 to 14 years were noninferior compared with a three-dose regimen…

Meeting News

Zika presence in the US raises concern about congenital infections

November 23, 2016
NEW YORK – Pediatricians should be wary of

FDA approval expands use of FluLaval influenza vaccine

November 21, 2016
GlaxoSmithKline announced its’ FluLaval Quadrivalent influenza vaccine has been approved by the FDA for use in children aged 6 months and

Meeting News

Implementation policies crucial to get global vaccination ‘back on track’

November 20, 2016
NEW YORK — Despite a reduction in child mortality rates worldwide over the last two decades, critical gaps remain in vaccine program…

Meeting NewsVideo

Maternal immunization confers needed infant protection against influenza, pertussis

November 20, 2016
NEW YORK — C. Mary Healy, MD, of the infectious diseases section at Baylor College of Medicine, discusses the importance of maternal…

More Headlines »